ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

FDMT 4D Molecular Therapeutics Inc

25.39
0.00 (0.00%)
Pre Market
Last Updated: 04:00:00
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 92k1.22M163k500k1.25M298k240k20.2M
Operating Income -24.76M-26.39M-28.43M-26.49M-28.72M-30.11M-32.14M-13.97M
Pre Tax Income -25.08M-26.34M-28.09M-25.69M-27.38M-28.68M-29.62M-10.26M
Net Income -25.08M-26.34M-28.09M-25.69M-27.38M-28.68M-29.62M-10.26M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -24.77M-26.44M-28.43M-26.49M-28.72M-30.13M-32.13M-14.13M
EBITDA -24.37M-25.99M-27.96M-25.98M-27.71M-29.08M-31.06M-12.98M
Year End December 30 2023 201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 14.13M6.99M13.61M18.04M3.13M20.72M
Operating Income -10.4M-50.76M-56.66M-71.33M-110.03M-112.87M
Pre Tax Income -9.55M-49.31M-56.69M-71.32M-107.49M-100.84M
Net Income -9.55M-49.31M-56.69M-71.32M-107.49M-100.84M
Preferred Dividends 000000
Basic Earnings Per Share (EPS) -1.863-9.52-2.125-2.213-3.295-2.359
EBIT -10.4M-50.81M-56.85M-71.45M-110.07M-113.05M
EBITDA -9.7M-49.76M-55.22M-69.81M-107.63M-108.66M

Your Recent History

Delayed Upgrade Clock